Days Inventory is also known as Days Sales of Inventory (DSI). Travere Therapeutics's Average Total Inventories for the
three
months ended in Dec. 2023 was $15.1 Mil. Travere Therapeutics's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $4.6 Mil.
Hence, Travere Therapeutics's Days Inventory for the
three
months ended in Dec. 2023 was 301.73.
The historical rank and industry rank for Travere Therapeutics's Days Inventory or its related term are showing as below:
TVTX'
s Days Inventory Range Over the Past 10 Years
Min: 214.88 Med: 407.92 Max: 713.22
Current: 338.78
During the past 13 years, Travere Therapeutics's highest Days Inventory was 713.22. The lowest was 214.88. And the median was 407.92.
TVTX's Days Inventory is ranked worse than 72.11% of 649
companies
in the Biotechnology industry
Industry Median: 191.36
vs TVTX: 338.78
Travere Therapeutics's Days Inventory
declined
from Dec. 2022 (621.30) to Dec. 2023 (301.73).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Travere Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Travere Therapeutics's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.33.
Travere Therapeutics Days Inventory Historical Data
The historical data trend for Travere Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Travere Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Travere Therapeutics Days Inventory Distribution
For the Biotechnology industry and Healthcare sector, Travere Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Travere Therapeutics's Days Inventory falls into.
Travere Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Travere Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Travere Therapeutics (NAS:TVTX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Travere Therapeutics's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Travere Therapeutics's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Travere Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of Travere Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Travere Therapeutics (Travere Therapeutics) Business Description
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TVTX has been successfully added to your 